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Abstract	
In	 many	 bacterial	 pathogens	 the	 second	messenger	 c-di-GMP	 stimulates	 the	 production	 of	 an	
exopolysaccharide	(EPS)	matrix	to	shield	bacteria	from	assaults	of	the	immune	system.	How	c-di-
GMP	 induces	 EPS	 biogenesis	 is	 largely	 unknown.	 Here	 we	 show	 that	 c-di-GMP	 allosterically	
activates	 the	 synthesis	 of	 poly-b-1,6-N-acetylglucosamine	 (poly-GlcNAc),	 a	 major	 extracellular	
matrix	component	of	Escherichia	coli	biofilms.	C-di-GMP	binds	directly	to	both	PgaC	and	PgaD,	the	
two	 inner	 membrane	 components	 of	 the	 poly-GlcNAc	 synthesis	 machinery	 to	 stimulate	 their	
glycosyltransferase	activity.	We	demonstrate	that	the	PgaCD	machinery	is	a	novel	type	c-di-GMP	
receptor,	where	ligand	binding	to	two	proteins	stabilizes	their	interaction	and	promotes	enzyme	
activity.	 This	 is	 the	 first	 example	of	 a	 c-di-GMP-mediated	process	 that	 relies	on	protein-protein	
interaction.	 At	 low	 c-di-GMP	 concentrations	 PgaD	 fails	 to	 interact	 with	 PgaC	 and	 is	 rapidly	
degraded.	 Thus,	 when	 cells	 experience	 a	 c-di-GMP	 trough,	 PgaD	 turnover	 facilitates	 the	
irreversible	 inactivation	of	 the	Pga	machinery,	 thereby	 temporarily	uncoupling	 it	 from	c-di-GMP	
signaling.	These	 data	 uncover	 the	mechanism	of	 c-di-GMP-mediated	 EPS	 control	 and	 provide	 a	
frame	for	c-di-GMP	signaling	specificity	in	pathogenic	bacteria.	 	
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Introduction	
Most	 bacteria	 are	 able	 to	 switch	 from	 a	 motile	 planktonic	 ‘lifestyle’	 to	 growth	 in	 surface-
associated	 multicellular	 communities	 known	 as	 biofilms.	 Within	 these	 structures,	 cells	 are	
encased	 in	 a	 self-produced	 extracellular	 polymeric	 matrix	 that	 is	 typically	 composed	 of	
proteinaceous	adhesin	factors,	DNA	and	exopolysaccharides	(EPS)	(Branda	et	al,	2005;	Flemming	
and	 Wingender,	 2010).	 This	 complex	 biofilm	 structure	 is	 known	 to	 protect	 bacteria	 from	
antimicrobials,	physical	stresses	and	the	predation	by	the	host	immune	system.	Bacterial	biofilms	
are	 often	 associated	with	 chronic	 infections	 and	 infection	 relapses	 causing	 health	 problems	 of	
growing	importance	(Costerton	et	al,	1999;	Mah	and	O’Toole,	2001;	Davies,	2003;	Hall-Stoodley	et	
al,	2004;	Fux	et	al,	2005).	
The	 second	 messenger	 bis-(3¢-5¢)-cyclic	 dimeric	 GMP	 (c-di-GMP)	 plays	 a	 central	 role	 in	
integrating	environmental	and	cellular	cues	to	control	this	major	bacterial	‘lifestyle’	transition	by	
disfavoring	single	cell	behavior	and	by	promoting	biofilm	formation.	C-di-GMP	is	synthesized	from	
GTP	by	diguanylate	cyclases	(DGCs)	that	harbor	a	conserved	GGDEF	domain	(Paul	et	al,	2004)	and	
is	 degraded	 to	 the	 linear	 dinucleotide	 pGpG	 by	 specific	 phosphodiesterases	 (PDEs)	 that	 harbor	
either	a	conserved	EAL	(Christen	et	al,	2005)	or	HD-GYP	domain	(Ryan	et	al,	2006;	Hengge,	2009;	
Schirmer	and	Jenal,	2009).	While	DGCs	and	PDEs	have	been	analyzed	 in	detail,	both	structurally	
and	functionally,	little	is	known	about	how	c-di-GMP	acts	on	downstream	targets.	Only	a	few	c-di-
GMP-specific	 receptor	 protein	 families	 have	 been	 described	 up	 to	 now,	 for	 most	 of	 which	
mechanistic	details	are	lacking	(Sondermann	et	al,	2011)	(Lee	2007;	Merighi	2007;	Christen	2007;	
Duerig	2009;	Newell	2011).	
In	Escherichia	coli,	c-di-GMP	regulates	several	cellular	processes	including	EPS	production,	the	
biogenesis	 of	 fimbriae,	 flagellar-based	 motility	 and	 RNA	 degradation	 (Pesavento	 et	 al,	 2008;	
Monteiro	et	 al,	 2009;	 Boehm	et	 al,	 2009;	 Tagliabue	et	 al,	 2010;	 Boehm	et	 al,	 2010;	 Paul	et	 al,	
2010;	 Fang	 and	 Gomelsky,	 2010;	 Tuckerman	 et	 al,	 2011;	 Povolotsky	 and	 Hengge,	 2012).	 To	
colonize	 surfaces,	E.	 coli	 produces	 the	EPS	poly-b-1,6-N-acetylglucosamine	 (poly-GlcNAc)	 (Wang	
et	 al,	 2004).	 This	 linear	 homopolymer	was	 implicated	 in	 biofilm	 formation	 in	 a	wide	 variety	 of	
pathogenic	 bacteria	 including	 Staphylococcus	 spp.	 and	 Yersinia	 pestis,	 where	 it	 can	 promote	
virulence	 and	 contribute	 to	 survival	 in	 the	 animal	 host	 (Maira-Litrán	et	 al,	 2005;	O’Gara,	 2007;	
Cerca	et	al,	2007;	Izano	et	al,	2007,	2008;	Bobrov	et	al,	2008;	Choi	et	al,	2009;	Becker	et	al,	2009;	
Conover	et	al,	2010;	Pérez-Mendoza	et	al,	2011;	Yakandawala	et	al,	2011;	Bentancor	et	al,	2012;	
Skurnik	et	al,	2012).	
In	E.	 coli,	 poly-GlcNAc	 is	 synthesized	 and	 secreted	 by	 the	 envelope-spanning	 Pga	machinery	
(Figure	1A),	which	is	encoded	by	the	pgaABCD	operon	(Wang	et	al,	2004).	While	PgaA	and	PgaB	
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are	 required	 for	 poly-GlcNAc	 export,	 PgaC	 and	 PgaD	 are	 necessary	 for	 poly-GlcNAc	 synthesis	
(Figure	1A)	(Itoh	et	al,	2008).	PgaA	is	an	outer	membrane	porin	that	serves	to	translocate	growing	
poly-GlcNAc	 chains	 to	 the	 cell	 surface	 (Itoh	 et	 al,	 2008).	 PgaB	 is	 a	 putative	 outer	 membrane	
lipoprotein	that	deacetylates	about	3%	of	the	GlcNAc	residues	during	poly-GlcNAc	export	(Wang	
et	al,	 2004;	 Itoh	et	al,	 2008).	 PgaC	 is	 a	processive	b-glycosyltransferase	 (GT)	of	 the	GT-2	 family	
that	 is	 located	 in	the	 inner	membrane	and	polymerizes	poly-GlcNAc	from	activated	UDP-GlcNAc	
precursor	(Saxena	and	Brown,	1997;	Wang	et	al,	2004;	Itoh	et	al,	2008).	The	catalytic	domain	of	
GT-2	family	members	is	exposed	to	the	cytoplasm	(Heldermon	et	al,	2001;	Ciocchini	et	al,	2006;	
Bobrov	et	al,	2008)	with	sugar	transfer	through	the	cytoplasmic	membrane	being	independent	of	
an	undecaprenyl	phosphate	lipid	carrier	(Gerke	et	al,	1998).	Finally,	PgaD	is	a	small	protein	with	
two	predicted	N-terminal	transmembrane	helices.	 Its	 function	 is	unknown	and	 it	does	not	show	
any	obvious	similarity	 to	other	protein	 families	or	domains.	However,	because	PgaD	 is	essential	
for	 poly-GlcNAc	 synthesis	 (Wang	et	 al,	 2004),	 it	was	 suggested	 to	 assist	 the	GT	 in	polymerizing	
poly-GlcNAc	(Itoh	et	al,	2008).	
The	 expression	 of	 the	 E.	 coli	 pgaABCD	 operon	 is	 tightly	 regulated	 on	 multiple	 levels.	 Most	
importantly,	 pgaABCD	 translation	 is	 repressed	 by	 the	 action	 of	 the	 RNA	 binding	 protein	 CsrA	
(carbon	 storage	 regulator	 A)	 (Wang	 et	 al,	 2005).	 This	 global	 regulator	 antagonistically	 controls	
numerous	cellular	pathways.	E.g.,	 it	promotes	motility,	glycolysis	and	virulence,	while	repressing	
EPS	production	and	gluconeogenesis	(Romeo	et	al,	1993;	Suzuki	et	al,	2006;	Timmermans	and	Van	
Melderen,	2010;	Romeo	et	al,	2012).	 In	addition,	CsrA	inhibits	the	expression	of	ydeH	and	ycdT,	
two	genes	encoding	DGCs	(Jonas	et	al,	2008).	The	observation	that	YdeH	stimulates	poly-GlcNAc-
dependent	biofilm	formation	(Boehm	et	al,	2009)	argued	that	the	expression	of	this	DGC	and	its	
target,	 the	Pga	machinery,	 is	coupled	via	CsrA.	YdeH	and	c-di-GMP	were	shown	to	control	poly-
GlcNAc	 biogenesis	 on	 a	 post-transcriptional	 level	 (Boehm	 et	 al,	 2009),	 but	 the	 mechanism	
responsible	for	this	induction	is	unknown.	
In	 this	 paper,	 we	 unravel	 a	 novel	 allosteric	 mechanism	 through	 which	 c-di-GMP	 stimulates	
poly-GlcNAc-dependent	 biofilm	 formation	 in	 E.	 coli.	 We	 show	 that	 c-di-GMP	 allosterically	
activates	the	PgaCD	GT	complex.	We	present	genetic	and	biochemical	evidence	arguing	that	c-di-
GMP	binds	to	both	inner	membrane	components	of	the	Pga	machinery,	thereby	mediating	their	
productive	interaction	and	the	formation	of	an	active	GT	complex.	Finally,	we	demonstrate	that	in	
the	 absence	 of	 c-di-GMP	 PgaD	 is	 rapidly	 degraded,	 offering	 the	 means	 to	 shut-off	 the	 Pga	
machinery	 in	 response	 to	 c-di-GMP	 fluctuations	 and	 to	 temporarily	 uncouple	 it	 from	 c-di-GMP	
signaling	in	the	absence	of	de	novo	synthesis	of	Pga	components.	These	studies	offer	a	molecular	
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frame	 for	 the	 widespread	 c-di-GMP-based	 activation	 of	 bacterial	 EPS	 systems	 and	 provide	 the	
basis	for	signaling	specificity	of	c-di-GMP-controlled	systems.	
	
	
Results	
PgaD	in	vivo	stability	depends	on	c-di-GMP	
We	have	previously	shown	that	PgaD	steady	state	protein	levels	are	positively	controlled	by	c-di-
GMP	on	a	post-transcriptional	 level	 (Boehm	et	al,	2009).	This	observation	was	used	as	an	entry	
point	 to	 address	 the	 molecular	 mechanism	 of	 c-di-GMP-regulated	 poly-GlcNAc	 biogenesis.	 To	
mimic	 the	 induced	 state	 of	 the	 Csr	 regulon,	 all	 assays	 were	 done	 in	 a	 partial	 loss-of-function	
csrA::Tn5	mutant	 strain	 background	 (Romeo	 et	 al,	 1993),	 which	 will	 be	 referred	 to	 as	 control	
strain	throughout	this	work.	In	order	to	monitor	all	Pga	complex	components	individually,	3xFlag-
tagged	versions	of	PgaA,	PgaB,	PgaC	and	PgaD	were	constructed.	In	the	absence	of	the	DGC	YdeH	
the	 protein	 levels	 of	 PgaD	 were	 reduced,	 while	 the	 levels	 of	 the	 other	 three	 Pga	 proteins	
remained	 constant,	 regardless	 of	 whether	 the	 pga	 operon	 was	 expressed	 from	 its	 native	
promoter	with	the	5¢	UTR	of	pgaA	or	from	the	L-arabinose-dependent	Para	promoter	with	the	5¢	
UTR	 of	 araB	 (Figure	 1B	 and	 Supplementary	 Figure	 1A).	 Moreover,	 PgaD	 levels	 were	 strongly	
reduced	in	a	∆pgaC	mutant,	but	were	restored	in	a	c-di-GMP-dependent	manner	when	pgaC	was	
expressed	 in	 trans	 and	were	 further	 increased	 upon	 overexpression	 of	 pgaC	 (Figure	 1C).	 PgaD	
levels	 were	 still	 c-di-GMP-dependent	 in	 cells	 expressing	 a	 pgaC	 active	 site	 mutant	 (D256N),	
arguing	 that	PgaC	protein	but	not	PgaC	glycosyltransferase	activity	 is	 required	 to	 stabilize	PgaD	
(Supplementary	 Figure	 1B).	 Finally,	 expression	 of	 the	 heterologous	 DGC	 dgcA	 (Christen	 et	 al,	
2006)	 strongly	 elevated	 PgaD	 levels	 in	 a	 ∆ydeH	 mutant,	 but	 only	 when	 pgaC	 was	 present	
(Supplementary	Figure	1C).	
The	 above	 data	 indicated	 that	 PgaC	 and	 c-di-GMP	 together	 control	 PgaD	 levels	 post-
translationally.	To	substantiate	this	and	to	demonstrate	that	the	effect	is	specific	for	PgaD,	pgaD	
was	replaced	with	yfiR,	an	unrelated	gene	 from	Pseudomonas	aeruginosa.	The	observation	that	
YfiR	 levels	 failed	 to	 fluctuate	 in	 response	 to	 c-di-GMP	 availability	 excludes	 the	 possibility	 that	
PgaD	 levels	 respond	 to	 a	 c-di-GMP-controlled	 promoter	 or	 to	 translation	 initiation	 control	
elements	within	pgaABC	(Supplementary	Figure	1D).	Next,	in	vivo	protein	stability	of	PgaD-3xFlag	
was	 determined	 under	 different	 c-di-GMP	 concentrations	 upon	 blocking	 de	 novo	 protein	
biosynthesis	in	exponentially	growing	cells.	While	PgaD	remained	stable	over	time	in	strains	with	
normal	 or	 increased	 c-di-GMP	 levels	 (control	 strain	 and	 ∆ydeH	 mutant	 expressing	 dgcA),	 the	
protein	was	rapidly	degraded	in	strains	with	low	cellular	c-di-GMP	concentrations	(∆ydeH	mutant	
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and	∆ydeH	mutant	expressing	an	active	site	mutant	of	dgcA)	(Figure	1D	and	Supplementary	Figure	
1E).	
In	summary,	these	data	suggest	that	c-di-GMP	positively	modulates	PgaD	protein	stability	in	a	
PgaC-dependent	manner.	
	
C-di-GMP	and	PgaD	together	promote	poly-GlcNAc-dependent	biofilm	formation	
The	E.	coli	csrA::Tn5	mutant	strain	(control	strain)	forms	biofilms	under	laboratory	conditions	that	
fully	depend	on	the	EPS	adhesin	poly-GlcNAc	(Wang	et	al,	2004).	To	test	 if	c-di-GMP	is	essential	
for	 poly-GlcNAc-dependent	 biofilm	 formation,	 multiple	 genes	 coding	 for	 potential	 DGCs	 (each	
containing	a	GGDEF	domain)	were	successively	deleted.	Concomitant	deletions	of	the	two	CsrA-
controlled	 genes	 ydeH	 and	 ycdT	 (Jonas	 et	 al,	 2008)	 resulted	 in	 a	 drastic	 reduction	 of	 biofilm	
formation,	while	a	strain	carrying	a	total	of	seven	deletions	(ydeH,	ycdT,	yegE,	yfiN,	yhjK,	ydaM,	
yneF)	 completely	 lost	 the	 ability	 to	 form	 biofilms	 (Figure	 1E).	 This	 strain	 showed	 a	 strongly	
reduced	cellular	c-di-GMP	level	in	comparison	to	the	control	strain	(Figure	1E)	and	will	be	referred	
to	 as	 ∆7	 strain	 throughout	 this	 work.	 Importantly,	 both	 biofilm	 deficiency	 and	 c-di-GMP	 level	
could	 be	 complemented	 by	 reintroducing	 only	 ydeH	 into	 the	 bacterial	 genome	 (Figure	 1E),	
supporting	 the	 idea	 that	YdeH	 represents	 the	major	DGC	 responsible	 for	poly-GlcNAc	 induction	
under	these	conditions	(Boehm	et	al,	2009).	In	line	with	the	data	described	above,	PgaD	protein	
was	 not	 detectable	 in	 the	 ∆7	mutant	 (Figure	 1E).	While	 c-di-GMP	 is	 required	 for	 normal	 PgaD	
levels	under	physiological	conditions,	overexpression	of	pgaD	resulted	in	a	biofilm	induction	both	
in	 the	 presence	 and	 in	 the	 absence	 of	 YdeH	 (Supplementary	 Figure	 1F).	 However,	 the	 ∆ydeH	
mutant	never	reached	the	same	level	of	biofilm	formation	as	the	control	strain,	arguing	that	PgaD	
and	c-di-GMP	are	synergistically	needed	for	optimal	biofilm	formation.	
	
C-di-GMP	enhances	PgaC-PgaD	interaction	
One	scenario	that	could	explain	PgaC-dependent	PgaD	stability	 is	a	direct	 interaction	of	the	two	
membrane	 proteins.	 Co-immunoprecipitation	 experiments	 using	 detergent-solubilized	
membranes	revealed	that	PgaC	and	PgaD	indeed	form	a	stable	complex	that	was	resistant	to	high	
salt	concentrations	and	up	to	2	M	urea	(Figure	2A).	When	overexpressed,	PgaC	and	PgaD	could	be	
co-purified	even	from	membranes	of	a	∆7	strain	(Figure	2B),	arguing	that	under	these	conditions	
c-di-GMP	 is	 no	 longer	 required	 for	 PgaD	 stability.	 Together,	 this	 suggested	 that	 PgaC	and	PgaD	
form	a	stable	complex	in	the	cytoplasmic	membrane,	the	formation	of	which	is	mediated	by	c-di-
GMP	under	physiological	conditions.	
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To	test	 if	c-di-GMP	is	 involved	in	PgaC-PgaD	interaction,	a	bacterial	two-hybrid	(BacTH)	assay	
was	 used	 that	 is	 based	 on	 the	 interaction-mediated	 reconstitution	 of	 the	 split	 cAMP	 signaling	
pathway	in	E.	coli	(Karimova	et	al,	1998).	In	this	assay,	full-length	PgaC	and	PgaD	showed	a	robust	
interaction	(Figure	2C),	while	all	truncated	variants	(e.g.	predicted	cytosolic	parts)	were	negative	
(Supplementary	 Table	 2).	 The	 interaction	 was	 stimulated	 by	 the	 ectopic	 expression	 of	 the	
heterologous	 DGC	 dgcA	 (Figure	 2D	 and	 Supplementary	 Figure	 2).	 Conversely,	 a	 step-wise	
reduction	 of	 the	 cellular	 c-di-GMP	 pool	 gradually	 lowered	 the	 interaction	 strength.	 PgaC-PgaD	
interaction	was	weakened	upon	deletion	of	ydeH	and	abolished	 in	 the	∆7	strain	 (Figure	2D	and	
Supplementary	 Figure	 2).	 These	 data	 further	 support	 the	 idea	 that	 c-di-GMP	 stimulates	 PgaC-
PgaD	interaction	or	complex	stability.	
The	 above	 results	 can	 be	 interpreted	 in	 two	 different	 ways.	 C-di-GMP	 could	 regulate	 poly-
GlcNAc	 production	 by	 determining	 PgaD	 stability	 and	 availability.	 Alternatively,	 c-di-GMP	 could	
promote	 PgaC-PgaD	 interaction	 with	 PgaD	 instability	 and	 degradation	 being	 a	 consequence	 of	
complex	disintegration	at	low	c-di-GMP	concentrations.	To	be	able	to	distinguish	between	these	
two	 possibilities,	 PgaD	 was	 ‘stabilized’	 under	 low	 c-di-GMP	 conditions	 by	 directly	 fusing	 its	 N-
terminus	 to	 the	C-terminus	of	PgaC.	Surprisingly,	 the	 resulting	pgaCD	 fusion	construct	 (pgaCDf)	
was	fully	functional	and	able	to	complement	biofilm	formation	of	a	∆pgaCD	mutant	in	a	c-di-GMP-
dependent	manner	 (Figure	 2E).	 But	 in	 contrast	 to	 PgaD,	 the	 level	 of	 the	 PgaCD	 fusion	 protein	
(PgaCDf)	was	unaltered	in	a	strain	with	lower	c-di-GMP	concentrations	(Figure	2E).	These	findings	
reinforce	the	notion	of	a	direct	interplay	between	PgaC	and	PgaD	and	imply	that	PgaD	instability	
at	low	c-di-GMP	levels	is	not	the	cause	for	Pga	control,	but	may	simply	result	from	weak	protein	
interactions	under	these	conditions.	These	data	raise	the	question	why	the	homologues	of	PgaC	
and	PgaD	exist	as	two	separate	proteins	in	all	bacteria	harboring	this	EPS	biogenesis	system	(see	
below).	
	
C-di-GMP	acts	as	an	allosteric	activator	of	PgaCD	glycosyltransferase	activity	
In	order	to	test	whether	c-di-GMP	acts	as	an	allosteric	activator	for	the	PgaCD	GT	complex,	an	in	
vitro	activity	assay	was	developed	with	membranes	containing	PgaCD.	GT	activity	was	determined	
indirectly	 using	 a	 modified	 enzyme-coupled	 spectrophotometric	 assay	 (Baykov	 et	 al,	 1988)	 or	
directly	 by	measuring	UDP-GlcNAc	 consumption.	 In	 agreement	with	 earlier	 data	 demonstrating	
that	both	PgaC	and	PgaD	are	needed	for	poly-GlcNAc	synthesis	in	vivo	(Wang	et	al,	2004;	Itoh	et	
al,	 2008),	 UDP-GlcNAc	 was	 only	 turned	 over	 to	 poly-GlcNAc	 and	 UDP	 by	 membranes	 of	 cells	
expressing	pgaC	and	pgaD	(Figure	3A).	Following	incubation	of	active	membranes	with	substrate	
for	several	hours,	a	slimy	and	viscous	reaction	product	was	visualized	by	light	microscopy	(Figure	
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3B).	 Immunoblot	 analysis	 with	 an	 anti-poly-GlcNAc	 antibody	 confirmed	 the	 identity	 of	 the	
reaction	product	 (Supplementary	Figure	3A).	Experiments	 to	determine	 the	substrate	affinity	of	
the	PgaCD	GT	complex	revealed	a	Km	 for	UDP-GlcNAc	of	270.5	±	37.2	µM	(Figure	3C).	To	 test	 if	
PgaCD	GT	activity	is	stimulated	by	c-di-GMP,	initial	reaction	velocities	were	measured	at	varying	c-
di-GMP	concentrations	in	the	presence	of	a	constant	UDP-GlcNAc	concentration	of	50	µM.	Under	
these	conditions,	c-di-GMP	stimulated	GT	activity	more	than	20-fold	and	curve	fitting	indicated	a	
c-di-GMP	concentration	 for	half-maximal	 initial	 velocity	 (Kact)	 of	62.2	±	7.2	nM	 (Figure	3D).	 This	
induction	 was	 highly	 specific	 as	 the	 addition	 of	 GTP	 failed	 to	 activate	 the	 enzyme	 and	
furthermore,	 the	 c-di-GMP-mediated	 activity	 was	 fully	 dependent	 on	 the	 PgaCD	 machinery	
(Supplementary	Figure	3B).	The	basal	enzymatic	GT	activity	in	the	absence	of	exogenously	added	
c-di-GMP	 correlated	 with	 the	 cellular	 c-di-GMP	 concentration	 of	 the	 strain	 used	 for	 pgaCD	
overexpression	 and	 membrane	 preparation.	 Almost	 no	 basal	 activity	 was	 detected	 for	
membranes	originating	 from	the	∆7	mutant	 (Supplementary	Figure	3B).	A	Lineweaver-Burk	plot	
analysis	 integrating	 initial	 reaction	 velocity	 data	 at	 different	 UDP-GlcNAc	 concentrations	 in	 the	
presence	 of	 a	 non-saturating	 and	 a	 saturating	 c-di-GMP	 concentration	 resulted	 in	 fitted	 lines	
converging	close	to	the	x-axis,	indicating	that	c-di-GMP	affects	the	Vmax	rather	than	the	Km	of	the	
enzyme	complex	(Figure	3E).	
In	summary,	 these	data	strongly	suggest	 that	c-di-GMP	acts	as	a	direct	allosteric	activator	of	
the	PgaCD	glycosyltransferase	complex.	
	
Concomitant	binding	of	c-di-GMP	to	both	PgaC	and	PgaD	
The	above	 in	vitro	assays	argued	for	a	direct	role	of	c-di-GMP	as	an	allosteric	activator	of	PgaCD	
GT	activity.	To	corroborate	these	findings,	c-di-GMP	binding	to	the	PgaCD	complex	was	tested	by	
using	a	c-di-GMP	capture	compound	(cdG-CC).	This	molecule	consists	of	a	c-di-GMP	moiety	that	is	
asymmetrically	modified	 at	 the	 2¢	 hydroxyl	 of	 one	 ribose	 with	 a	 linker	 connecting	 to	 a	 photo-
reactive	and	a	biotin	sorting	group	(Nesper	et	al,	2012).	The	PgaCD	complex	was	specifically	and	
competitively	captured	by	the	cdG-CC	from	membrane	preparations	(Figure	4A).	An	excess	of	c-
di-GMP,	but	not	GTP,	gradually	competed	with	cdG-CC	binding.	While	the	PgaCD	complex	and	the	
PgaCD	 fusion	 protein	 were	 specifically	 pulled-down,	 no	 specific	 binding	 was	 observed	 when	
membranes	 were	 used	 that	 only	 contained	 PgaC	 or	 PgaD	 (Figure	 4B).	 Although	 some	 residual	
binding	 to	 the	 cdG-CC	was	 observed	 under	 these	 conditions,	 the	 addition	 of	 an	 excess	 of	 c-di-
GMP	 failed	 to	 compete	 with	 this	 interaction	 (Figure	 4B).	 When	 membranes	 were	 used	 that	
contained	3xFlag-tagged	variants	of	both	PgaC	and	PgaD,	both	proteins	showed	specific	 cdG-CC	
binding.	 A	 fraction	 of	 the	 PgaC-PgaD	 heterodimers	withstood	 boiling	 in	 SDS	 sample	 buffer	 and	
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appeared	 as	 a	 distinct	 band	on	 the	 immunoblot,	 emphasizing	 the	 remarkable	 stability	 of	 these	
complexes	(Figure	4B).	Probing	cdG-CC	samples	with	an	antibody	against	the	biotin	moiety	of	the	
capture	compound	revealed	that	the	cdG-CC	was	covalently	crosslinked	to	both	PgaC	and	PgaD	in	
a	competitive	way,	suggesting	that	c-di-GMP	is	able	to	directly	interact	with	both	components	of	
the	complex	(Supplementary	Figures	4A	and	4B).	
To	corroborate	these	findings,	UV	light-induced	crosslinking	experiments	with	radiolabeled	c-
di-GMP	were	performed	 (Christen	et	al,	2006).	 In	good	agreement	with	 the	data	obtained	with	
the	capture	compound,	PgaC	and	PgaD	were	specifically	and	competitively	labeled	with	[33P]c-di-
GMP	when	both	proteins	were	present	 in	the	membrane	fraction	(Figure	4C).	An	excess	of	c-di-
GMP,	 but	 not	 GTP,	 efficiently	 outcompeted	 the	 [33P]c-di-GMP	 crosslink	 to	 both	 proteins.	 It	 is	
interesting	 to	 note	 that	 PgaC	 labeling	 was	 generally	much	 stronger	 than	 PgaD	 labeling.	 Again,	
specific	 c-di-GMP	 binding	 and	 radiolabeling	 was	 only	 observed	 in	 membranes	 containing	 both	
proteins,	 but	 was	 lost	 for	 PgaC	 when	 PgaD	 was	 not	 present	 (Figure	 4D).	 Interestingly,	 the	
presence	of	the	substrate	UDP-GlcNAc	increased	the	specific	binding	of	c-di-GMP,	indicating	some	
form	of	 communication	 between	 the	GT	 active	 site	 and	 the	 allosteric	 c-di-GMP	binding	 pocket	
within	the	PgaCD	complex	(Supplementary	Figures	4C	and	4D).	
Altogether,	these	data	suggest	that	the	PgaCD	GT	complex	represents	a	novel	type	c-di-GMP	
receptor,	where	 ligand	binding	 to	 two	 individual	proteins	promotes	 their	 stable	 interaction	and	
subsequent	activation.	
	
Constitutive	mutations	in	pgaD	uncouple	PgaCD	activity	from	c-di-GMP	
To	more	 closely	 define	 the	 c-di-GMP	 binding	 site	 in	 PgaD,	 variants	with	 C-terminal	 truncations	
were	 analyzed	 for	 their	 ability	 to	 stimulate	 biofilm	 formation.	 Although	 biofilm	 formation	
gradually	decreased	with	deletions	extending	towards	the	second	transmembrane	helix,	c-di-GMP	
stimulation	was	 sustained	 in	 truncations	extending	 to	amino	acid	R78	 (Figures	5A	and	5B).	This	
argued	that	c-di-GMP	binds	to	a	region	within	the	first	78	amino	acids	of	PgaD	consisting	of	only	
two	transmembrane	helices	with	short	flanking	regions	in	the	cytoplasm,	thus	suggesting	that	c-
di-GMP	modulates	the	interaction	of	PgaC	and	PgaD	in	the	vicinity	of	the	cytoplasmic	membrane.	
To	 test	 this	 hypothesis	we	 set	 up	 a	 genetic	 screen	 to	 isolate	mutations	 in	pgaC	 and	pgaD	 that	
facilitate	 biofilm	 formation	 in	 the	 absence	 of	 c-di-GMP.	 Error-prone	 PCR	 mutagenesis	 and	
screening	 for	 biofilm-forming	 colonies	 in	 the	 ∆7	 strain	 using	 Congo	 Red	 agar	 plates	 led	 to	 the	
isolation	 of	 several	 constitutive	 mutants	 (Supplementary	 Table	 3).	 With	 one	 exception,	 all	
mutations	in	PgaD	clustered	within	a	short	conserved	region	between	the	second	transmembrane	
helix	 and	 residue	 R78	 (Figure	 5A).	 Two	 of	 the	 activating	 pgaD	 alleles	 (N75D,K76E	 and	
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L73Q,K76E,R78C)	 firmly	 locked	biofilm	 formation	 at	 an	 intermediate	 level	 independently	 of	 the	
availability	 of	 c-di-GMP	 (Figure	 5C).	 In	 both	 cases	 this	 constitutive	 phenotype	 required	 the	
presence	of	multiple	mutations	with	single	changes	showing	no	or	little	effect	(Figure	5C).	While	
the	 N75D,K76E	 mutant	 completely	 failed	 to	 respond	 to	 c-di-GMP,	 the	 L73Q,K76E,R78C	 allele	
retained	some	residual	induction	upon	ectopic	expression	of	a	heterologous	DGC	(Supplementary	
Figure	5A).	 Interestingly,	protein	 levels	of	both	constitutive	PgaD	mutants	were	 increased	in	the	
∆7	 strain,	 but	 in	 contrast	 to	wild-type	PgaD	 they	 showed	no	 significant	 response	 to	 changes	 in	
cellular	 c-di-GMP	 concentration	 (Figure	 5D).	 The	 stability	 of	 these	 mutant	 forms	 was	 still	
dependent	on	the	presence	of	PgaC	(data	not	shown).	
Next,	the	behavior	of	the	PgaD	mutant	forms	was	assayed	in	the	in	vitro	GT	activity	assay.	To	
avoid	possible	stoichiometry	problems	arising	 from	different	overall	 levels	of	PgaD,	assays	were	
performed	with	normalized	protein	levels	of	the	PgaCD	fusion	protein	(Supplementary	Figure	5B).	
Both	mutant	proteins	 showed	a	more	 than	3-fold	 increased	basal	GT	activity	 in	 the	 absence	of	
exogenously	added	c-di-GMP	and	could	not	be	stimulated	further	by	the	addition	of	100	nM	c-di-
GMP,	a	concentration	that	causes	approximately	half-maximal	activation	of	the	wild-type	enzyme	
(Figures	 5E	 and	 3D).	 These	 data	 suggested	 that	 constitutive	 PgaD	mutants	 are	 able	 to	 interact	
with	and	stimulate	PgaC	in	the	absence	of	c-di-GMP,	thereby	uncoupling	the	PgaCD	complex	from	
c-di-GMP	 signaling.	 To	 test	 if	 these	 mutants	 still	 bind	 the	 allosteric	 ligand	 in	 vitro,	 cdG-CC	
experiments	were	performed	in	the	context	of	the	PgaCD	fusion	protein.	Consistent	with	the	data	
described	above,	the	N75D,K76E	mutant	almost	completely	failed	to	bind	the	cdG-CC,	while	the	
pull-down	of	 the	 L73Q,K76E,R78C	mutant	was	 severely	 reduced	 (Figure	5F).	 These	experiments	
demonstrate	 that	 specific	mutations	 in	 the	 conserved	 region	 of	 PgaD	 abolish	 c-di-GMP	binding	
and	at	the	same	time	mimic	a	c-di-GMP-bound	state	that	activates	the	PgaCD	GT	complex.	
Two	 conserved	 residues	 of	 PgaD	 located	 within	 the	 same	 region,	 W71	 and	 Y74,	 were	
previously	shown	to	be	important	for	the	function	of	the	PgaD	homologue	of	Y.	pestis	(Forman	et	
al,	 2006).	 While	 the	 Y74A	 mutation	 did	 not	 affect	 E.	 coli	 PgaD	 function,	 the	 W71A	 mutation	
resulted	in	an	almost	complete	loss	of	biofilm	formation	(Figure	5C).	Importantly,	while	W71	was	
not	 required	 for	 cdG-CC	 binding	 (Figure	 5F),	 the	 W71A	 mutation	 was	 dominant	 over	 the	
constitutive	 allele	 N75D,K76E	 (Supplementary	 Figure	 5C).	 This	 argues	 that	 W71	 resides	
downstream	of	the	c-di-GMP-mediated	activation	in	the	PgaD	signal	transduction	process.	
	
Constitutive	mutations	in	pgaC	influence	PgaD	protein	levels	
In	 contrast	 to	 the	 constitutive	pgaD	mutants,	 all	 activating	mutations	 isolated	 in	pgaC	 retained	
some	level	of	c-di-GMP	stimulation	(Figure	6A	and	Supplementary	Table	3).	Moreover,	they	all	still	
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depended	on	the	presence	of	PgaD	for	biofilm	formation	 (data	not	shown).	 In	case	of	 the	pgaC	
S7P,M44T,W60R	 allele,	 the	 combination	 of	 three	 mutations	 contributes	 to	 the	 high	 level	 of	
biofilm	 formation	 in	 a	 ∆7	 strain	 (Figure	 6A).	 In	 contrast,	 the	 single	 mutation	 V227L	 strongly	
upregulated	biofilm	formation	both	in	the	∆7	strain	and	in	a	strain	expressing	diguanylate	cyclases	
(Figure	6A).	Co-expression	of	the	pgaC	V227L	allele	with	the	constitutive	pgaD	N75D,K76E	mutant	
increased	biofilm	formation	up	to	 the	 fully	 induced	 level	observed	 for	 the	V227L	single	mutant,	
even	when	c-di-GMP	was	absent	(Supplementary	Figure	6A).	These	data	indicate	that	PgaC	V227L	
partially	 uncouples	 PgaCD	GT	 activity	 from	 c-di-GMP,	while	 the	 PgaD	mutant	N75D,K76E	 has	 a	
strong	 dominant	 effect	 that	 fully	 releases	 the	 PgaCD	 complex	 from	 its	 c-di-GMP	 dependency.	
Because	PgaC	and	c-di-GMP	are	required	for	PgaD	stability	 in	vivo	 (see	above),	we	hypothesized	
that	constitutive	pgaC	mutants	should	lead	to	enhanced	PgaD	levels	in	the	absence	of	c-di-GMP.	
As	 shown	 in	 Figure	 6B,	 PgaD	was	markedly	 stabilized	 in	 ∆7	 strains	 expressing	 either	 the	 triple	
pgaC	mutant	S7P,M44T,W60R	or	the	single	V227L	allele.	This	further	substantiates	the	idea	that	
c-di-GMP	 stimulation	 primarily	 affects	 PgaC-PgaD	 interaction,	 while	 PgaD	 stability	 is	 merely	 a	
consequence	of	the	allosteric	control	of	the	Pga	machinery.	
	
R222	of	PgaC	plays	an	essential	role	in	c-di-GMP-dependent	PgaCD	activation	
In	order	to	identify	regions	of	PgaC	involved	in	c-di-GMP	binding,	we	focused	on	arginines	as	they	
were	shown	to	play	a	critical	role	in	c-di-GMP	binding	(Benach	et	al,	2007;	Habazettl	et	al,	2011).	
To	 identify	 conserved	 arginines	 potentially	 involved	 in	 c-di-GMP	 binding,	 PgaC	 sequences	 from	
gram-negative	 bacteria	 harboring	 genes	 encoding	 GGDEF	 and	 EAL	 domain	 proteins	 were	
compared	to	PgaC	sequences	from	gram-negative	organisms	lacking	c-di-GMP	(no	GGDEF	domain	
proteins)	(Supplementary	Figure	6D).	Based	on	this	analysis,	the	following	six	residues,	which	are	
only	 conserved	 in	 species	 with	 GGDEF	 domains,	 were	 selected	 and	 changed	 to	 alanines	
individually	 or	 in	 combination:	 R56,	 R58,	 R133,	 R222,	 R428	 and	 R430.	 Two	 alleles,	 R222A	 and	
R428A,R430A,	were	identified	that	produced	normal	protein	levels	in	vivo	(Supplementary	Figure	
6B),	but	almost	completely	failed	to	support	biofilm	formation	(Figure	6C).	The	R222A	but	not	the	
R428A,R430A	 mutant	 also	 showed	 a	 strong	 binding	 defect	 for	 the	 cdG-CC	 (Figure	 6D).	 In	
agreement	 with	 a	 specific	 role	 for	 R222	 in	 c-di-GMP	 binding,	 cells	 expressing	 the	 pgaC	 R222A	
allele	were	unable	 to	stabilize	PgaD.	 In	contrast,	PgaD	was	stabilized	by	 the	PgaC	GT	active	site	
mutant	(D256N)	in	a	c-di-GMP-dependent	manner	(Supplementary	Figure	6C).	Most	importantly,	
when	 co-expressed	with	 the	 constitutive	pgaD	 allele	N75D,K76E,	 the	 PgaC	R222A	 function	was	
restored	 (Figure	 6E).	 This	 underscores	 the	 tight	 interplay	 between	 PgaC	 and	 PgaD	 and	
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demonstrates	that	the	R222A	mutation	does	not	cause	a	general	loss	of	PgaC	activity,	but	rather	
specifically	affects	c-di-GMP	binding	and	GT	activation.	
Together,	 these	 data	 suggested	 a	 critical	 role	 for	 R222	 of	 PgaC	 in	 the	 c-di-GMP-dependent	
activation	 of	 the	 PgaCD	 GT	 complex	 and	 implied	 that	 R222	 is	 directly	 involved	 in	 c-di-GMP	
binding.	To	test	this,	UV	light-induced	crosslinking	experiments	with	radiolabeled	c-di-GMP	were	
performed.	As	shown	in	Figure	7,	both	PgaC	and	PgaD	specifically	and	competitively	incorporated	
radiolabeled	 c-di-GMP	 when	 present	 in	 wild-type	 GT	 complexes.	 In	 contrast,	 GT	 complexes	
containing	either	PgaD	N75D,K76E	or	PgaC	R222A	were	strongly	impaired	in	c-di-GMP	binding.	In	
both	cases,	the	total	amount	of	crosslinked	[32P]c-di-GMP	was	reduced	in	PgaC	as	well	as	in	PgaD	
(Figures	 7A	 and	 7B	 and	 Supplementary	 Figure	 7),	 arguing	 that	 individual	 binding	 mutations	 in	
PgaC	or	PgaD	affect	 the	overall	 binding	of	 the	 complex.	This	 is	 consistent	with	 the	observation	
that	cdG-CC	binding	to	the	PgaCD	complex	was	strongly	reduced	for	the	PgaD	N75D,K76E	and	the	
PgaC	R222A	mutant	(Figures	5F	and	6D).	Altogether,	these	data	strongly	support	the	idea	that	c-
di-GMP	binds	to	both	PgaC	and	PgaD,	resulting	in	the	tight	interaction	and	activation	of	the	PgaCD	
GT	complex.	
	
	
Discussion	
To	 transit	 from	 a	 planktonic,	 single	 cell	 to	 a	 biofilm-associated	 community	 ‘lifestyle’	 bacteria	
undergo	 a	 complex	 and	highly	 regulated	process	 that	 is	 globally	 coordinated	by	 the	ubiquitous	
bacterial	second	messenger	c-di-GMP	(Schirmer	and	Jenal,	2009;	Hengge,	2009).	One	of	the	key	
cellular	 processes	 directly	 stimulated	 by	 c-di-GMP	 is	 the	 production	 and	 secretion	 of	
exopolysaccharides	 that	 serve	 as	protective	biofilm	matrix.	 Recently,	 several	 c-di-GMP	 receptor	
proteins	were	identified	that	regulate	EPS	production	(Amikam	and	Galperin,	2006;	Merighi	et	al,	
2007;	Lee	et	al,	2007;	Whitney	et	al,	2012).	However,	their	mode	of	action	has	remained	elusive.	
To	address	the	molecular	principles	of	c-di-GMP-induced	EPS	production	we	have	chosen	the	E.	
coli	Pga	 system	primarily	 for	 reasons	of	 its	 relatively	 simple	architecture.	The	secretion	of	poly-
GlcNAc	by	the	Pga	machinery	was	linked	to	c-di-GMP	signaling	earlier	(Kirillina	et	al,	2004;	Boehm	
et	 al,	 2009;	 Tagliabue	 et	 al,	 2010;	 Pérez-Mendoza	 et	 al,	 2011).	 However,	 the	 molecular	
mechanisms	involved	remained	unclear	and,	despite	of	obvious	analogies	to	other	EPS	secretion	
systems,	none	of	the	canonical	c-di-GMP	receptor	domains	is	part	of	the	Pga	system.	
	
We	showed	previously	that	the	Pga	system	is	regulated	by	c-di-GMP	on	the	post-transcriptional	
level	 (Boehm	 et	 al,	 2009).	 In	 this	 study,	 we	 close	 the	 gap	 by	 demonstrating	 that	 c-di-GMP	
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allosterically	regulates	the	PgaCD	glycosyltransferase	complex	in	the	inner	membrane.	The	PgaCD	
complex	 represents	a	novel	 type	 c-di-GMP	 receptor,	 in	which	both	membrane-integral	proteins	
contribute	 to	 ligand	 binding,	 thereby	 mediating	 robust	 interaction,	 PgaD	 stabilization	 and	
activation	 of	 the	 two	 partners.	 This	 is	 the	 first	 example	 of	 a	 c-di-GMP	 receptor	 that	 relies	 on	
protein-protein	 interaction.	 Several	 lines	 of	 evidence	 support	 these	 findings.	 Only	 a	 PgaCD	
complex,	but	not	PgaC	or	PgaD	alone,	showed	specific	and	competitive	ligand	binding.	Moreover,	
UV-crosslinking	 of	 radiolabeled	 c-di-GMP	 consistently	 and	 specifically	 labeled	 both	 PgaC	 and	
PgaD.	Because	of	the	close	proximity	that	is	needed	for	covalent	zero-length	crosslink	formation,	
this	strongly	 implies	that	amino	acid	residues	from	both	proteins	participate	in	the	formation	of	
the	 ligand-binding	pocket.	The	observation	 that	PgaC	was	 incorporating	more	radioactivity	 than	
PgaD	could	 reflect	 the	nature	of	 the	c-di-GMP	binding	pocket,	 since	not	all	amino	acid	 residues	
show	 the	 same	 propensity	 for	 covalent	 crosslinking	 to	 a	 nucleotide	 ligand	 upon	 UV	 light	
irradiation	 (Meisenheimer	 and	 Koch,	 1997).	 These	 results	 strongly	 argue	 against	 the	 possibility	
that	 the	 c-di-GMP	 binding	 pocket	 is	 entirely	 contained	 within	 PgaC	 with	 PgaD	 triggering	 the	
binding-competent	 conformation	 of	 its	 partner.	 Concomitant	 binding	 of	 c-di-GMP	 to	 PgaC	 and	
PgaD	 is	 further	 supported	 by	 genetic	 evidence.	 We	 isolated	 pgaD	 alleles	 that	 uncoupled	 the	
PgaCD	complex	from	c-di-GMP	signaling	in	terms	of	c-di-GMP	binding,	allosteric	GT	activation	and	
biofilm	formation.	These	constitutive	mutations	cluster	within	a	short,	positively	charged	region	
proximal	to	the	second	membrane-spanning	domain	of	PgaD	that	 likely	contributes	to	c-di-GMP	
binding.	 In	 contrast,	 none	 of	 the	 activating	 pgaC	 alleles	 showed	 a	 completely	 c-di-GMP-‘blind’	
phenotype,	emphasizing	the	important	role	of	PgaD	in	c-di-GMP-mediated	GT	activation.	
	
Both	 in	vivo	and	 in	vitro	data	suggest	that	c-di-GMP	is	absolutely	essential	for	PgaCD	GT	activity	
and	 poly-GlcNAc-dependent	 biofilm	 formation.	 Our	 data	 indicate	 that	 c-di-GMP	 binds	 to	 the	
PgaCD	 complex	with	 high	 affinity	 (Kact	 =	 62	 nM).	 Interestingly,	 c-di-GMP	 increased	 the	 velocity	
(Vmax)	of	the	GT	complex,	but	not	the	affinity	for	 its	substrate	UDP-GlcNAc.	This	 is	similar	to	the	
findings	 with	 cellulose	 synthase	 (Aloni	 et	 al,	 1983;	 Ross	 et	 al,	 1987)	 and	 implies	 that	 UDP-
activated	 sugar	 molecules	 are	 not	 limiting	 under	 conditions	 that	 favor	 EPS	 synthesis	 and	
secretion.	This,	in	turn,	is	in	good	agreement	with	the	fact	that	the	Km	of	PgaCD	(270	µM)	lies	well	
within	the	range	of	reported	cellular	UDP-GlcNAc	concentrations	in	E.	coli	(Mengin-Lecreulx	et	al,	
1989;	Namboori	and	Graham,	2008).	The	strong	effect	of	c-di-GMP	on	PgaCD	activity	 raises	 the	
question	of	how	the	second	messenger	stimulates	this	enzyme	complex.	PgaC	is	a	member	of	the	
processive	GT-2	b-glycosyltransferase	family,	which	are	thought	to	function	as	monomers	making	
use	of	two	active	site-containing	domains,	A	and	B,	for	the	sugar	polymerization	reaction	(Saxena	
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and	Brown,	1997;	Tlapak-Simmons	et	al,	1998;	Ciocchini	et	al,	2006).	But	how	would	a	growing	
polysaccharide	 chain	 be	 efficiently	 transferred	 across	 the	 hydrophobic	 membrane	 lipid	 barrier	
with	as	little	as	four	transmembrane	domains	(TMDs)	(Bobrov	et	al,	2008)?	For	the	Streptococcus	
hyaluronan	synthase,	a	structural	homologue	of	PgaC,	the	interaction	with	cardiolipin	molecules	
was	suggested	as	a	solution	to	this	‘transfer	dilemma’	(Tlapak-Simmons	et	al,	1999).	Based	on	our	
findings	of	c-di-GMP-mediated	PgaCD	complex	activation,	we	propose	a	central	 role	 for	PgaD	 in	
converting	the	PgaC	GT	into	a	secretion-competent	conformation.	In	our	model	c-di-GMP	binding	
to	both	PgaC	and	PgaD	 induces	a	conformational	change	that	causes	the	 integration	of	 the	two	
transmembrane	helices	of	PgaD	 into	the	core	of	 transmembrane	domains	 formed	by	PgaC.	This	
would	convert	 the	 loosely	associated	GT	complex	 into	a	 stable,	active	and	secretion-competent	
heterodimeric	complex	by	opening	up	a	pore	for	poly-GlcNAc	translocation	across	the	cytoplasmic	
membrane	(Figures	8A	and	8B).	The	presence	of	the	two	membrane-associated	domains	(MADs)	
3	 and	 6	 in	 the	 PgaC	 architecture	 of	 our	 model	 is	 based	 on	 the	 membrane	 topology	 model	
determined	for	the	Streptococcus	hyaluronan	synthase,	a	homologous	protein	(Heldermon	et	al,	
2001).	In	line	with	this,	bioinformatic	predictions	indicate	an	increased	probability	for	membrane	
association	of	regions	3	and	6	of	PgaC.	It	is	thus	possible	that	the	c-di-GMP-stimulated	interaction	
between	 PgaC	 and	 PgaD	 recruits	 MADs	 3	 and	 6	 of	 PgaC	 into	 a	 secretion-competent	
transmembrane	 pore	 (Figure	 8B).	 The	 regions	 in	 PgaC	 (R222)	 and	 PgaD	 (NKLR)	 proposed	 to	 be	
involved	in	the	formation	of	the	c-di-GMP	binding	site	are	well	positioned	to	bring	together	PgaC	
MAD3	and	PgaD	TMD2	(Figures	8A	and	8B).	Such	an	arrangement	would	also	explain	the	strong	
constitutive	effect	of	the	PgaC	mutant	V227L,	as	this	mutation	is	located	at	the	N-terminal	face	of	
MAD3,	in	the	immediate	vicinity	of	the	proposed	c-di-GMP	binding	site	(Figure	8A).	The	formation	
of	 a	 membrane-integral	 heterodimeric	 complex	 as	 a	 functional	 secretion	 unit	 is	 the	 simplest	
model	 to	 concur	 with	 our	 findings	 that	 a	 PgaCD	 fusion	 protein	 is	 fully	 functional,	 that	 both	
proteins	are	absolutely	 required	 for	poly-GlcNAc	synthesis	 in	vivo	 and	 in	vitro	 and	 that	 the	 two	
transmembrane	 domains	 are	 the	 critical	 functional	 determinants	 of	 PgaD.	 Moreover,	 the	
observation	 that	 PgaD	 is	 strictly	 required	 for	 poly-GlcNAc	 secretion	 is	 in	 line	 with	 a	 structural	
requirement	 for	 this	protein.	 The	association	of	 the	GT	with	a	 second	 inner	membrane	protein	
essential	 for	 its	 activity	 seems	 to	 be	 a	 general	 phenomenon	 of	 homopolymeric	 EPS	 secretion	
systems	(Keiski	et	al,	2010).	
	
Among	the	organisms	harboring	a	Pga-like	poly-GlcNAc	secretion	system	two	subfamilies	of	PgaD	
proteins	 exist.	 All	 gram-negative	 bacteria	 that	 are	 devoid	 of	 c-di-GMP	 signaling	 harbor	 a	
Staphylococcus	epidermidis	IcaD-like	(Gerke	et	al,	1998)	homologue,	while	the	presence	of	GGDEF	
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domains	 strongly	 correlates	with	PgaD-like	proteins	 (and	 the	presence	of	R222	 in	PgaC).	 This	 is	
striking	 since	 evidence	 is	 accumulating	 that	 Staphylococcus	 spp.	 are	 unable	 to	 synthesize	 c-di-
GMP	(Holland	et	al,	2008).	It	can	thus	be	speculated	that	PgaD-like	partners	of	the	PgaC	GT	family	
interlink	the	activity	of	this	EPS	system	with	the	cell’s	c-di-GMP	circuitry.	The	observation	that	a	
PgaCD	 fusion	 protein	 is	 fully	 functional	 and	 responsive	 to	 c-di-GMP	 raised	 the	 question	 why	
nature	has	 split	 this	 functional	unit	 into	 two	 individual	polypeptides.	We	would	 like	 to	propose	
that	the	answer	to	this	question	is	linked	to	the	observed	instability	of	PgaD	when	cellular	levels	
of	 c-di-GMP	are	 low.	Rapid	 removal	 of	 PgaD	under	 these	 conditions	would	 irreversibly	 shut-off	
the	Pga	machinery	and	temporarily	uncouple	poly-GlcNAc	synthesis	and	secretion	from	cellular	c-
di-GMP	levels	(Figure	8C).	Reinstating	poly-GlcNAc	production	in	cells	that	went	through	a	trough	
of	 c-di-GMP	 would	 require	 a	 derepressed	 Csr	 pathway	 allowing	 the	 resynthesis	 of	 all	 Pga	
components.	Such	a	mechanism	would	thus	elegantly	equip	the	global	Csr	pathway	(Timmermans	
and	Van	Melderen,	2010;	Romeo	et	al,	2012)	with	a	clear	dominance	over	short-term	fluctuations	
of	c-di-GMP	resulting	 from	signal	 input	 into	different	DGCs	and	PDEs,	and	by	that	providing	the	
basis	for	signaling	specificity	of	c-di-GMP-controlled	systems	(Figure	8C).	
In	 conclusion,	 this	 work	 shows	 that	 in	 E.	 coli,	 poly-GlcNAc-dependent	 biofilm	 formation	 is	
allosterically	 controlled	 through	 c-di-GMP	 binding	 to	 the	membrane-anchored	 PgaCD	 complex.	
Since	two	proteins	have	to	interact	in	order	to	form	a	ligand-binding	pocket,	the	PgaCD	complex	
represents	 a	 novel	 type	 c-di-GMP	 receptor.	 The	 elucidation	 of	 the	 details	 of	 the	 specific	
interaction	between	the	allosteric	ligand	and	the	PgaCD	complex	will	require	careful	biochemical	
and	structural	analysis.	
	
	
Materials	and	methods	
More	detailed	descriptions	of	Materials	and	methods	are	provided	in	the	Supplementary	data.	
	
Membrane	preparation	
Overnight	 pre-cultures	 of	 strains	 AB1638	 or	 AB2043	 harboring	 the	 desired	 plasmid	 for	 protein	
overexpression	(or	strains	AB1775,	AB1776	and	AB1777)	were	diluted	1:100	into	1	L	LB	medium	
and	cultures	were	grown	at	30°C	to	OD600	of	0.2,	before	expression	of	plasmid-borne	genes	was	
induced	with	0.2%	L-arabinose	for	5	h.	Cells	were	harvested	by	centrifugation,	resuspended	in	5-
10	ml	 ice-cold	French	Press	Buffer	(50	mM	HEPES	pH	7,	5	mM	CaCl2,	1	mM	DTT,	Complete	Mini	
EDTA-free	 protease	 inhibitors	 (Roche))	 and	 lysed	 by	 passage	 three	 times	 through	 a	 French	
pressure	cell	(Vanderheiden	et	al,	1970).	Lysate	was	clarified	by	centrifugation	(27’000	g,	70	min,	
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4°C),	 before	 membranes	 were	 pelleted	 by	 ultracentrifugation	 (120’000	 g,	 90	 min,	 4°C).	
Membranes	were	generally	resuspended	in	~250	µl	French	Press	Buffer	and	stored	at	-80°C.	
	
Glycosyltransferase	(GT)	activity	assays	
Modified	enzyme-coupled	spectrophotometric	assay.	PgaCD	GT	activity	was	indirectly	determined	
with	 a	 modified	 enzyme-coupled	 spectrophotometric	 assay	 (Baykov	 et	 al,	 1988).	 Briefly,	 50	µl	
reaction	mixtures	containing	membranes	from	strains	AB1775,	AB1776	or	AB1777	(approximately	
10	mg/ml	total	protein)	in	GT	Activity	Buffer	(50	mM	HEPES	pH	7,	5	mM	CaCl2,	5	mM	MgCl2)	were	
incubated	 for	 5	 h	 at	 30°C	 with	 or	 without	 2	 mM	 UDP-GlcNAc.	 The	 pH	 of	 the	 reactions	 was	
increased	to	8-8.5	by	adding	0.1	M	NaOH	and	taking	them	up	in	SAP	Buffer	(50	mM	Tris	HCl	pH	9,	
10	mM	MgCl2),	 before	 reactions	were	 incubated	with	 1.5	µl	 shrimp	alkaline	phosphatase	 (SAP)	
(Promega)	 for	 80	min	 at	 37°C.	 Phosphate	 content	 (indirect	measure	 for	 UDP)	 was	 determined	
spectrophotometrically	 at	 630	 nm	using	 the	 color	 reagent	 containing	molybdate	 and	malachite	
green	(Baykov	et	al,	1988).	Background	value	was	subtracted.	
FPLC	anion	exchange	column	assay.	Standard	100	µl	reaction	mixtures	contained	membranes	
from	strain	AB2043	harboring	the	desired	plasmid	for	protein	overexpression	(approximately	0.3-
0.6	mg/ml	 total	 protein),	 varying	UDP-GlcNAc	 concentrations	 (between	 50	µM	and	 2	mM)	 and	
different	c-di-GMP	concentrations	(between	0	µM	and	2	µM)	in	GT	Activity	Buffer	(50	mM	HEPES	
pH	7,	5	mM	CaCl2,	5	mM	MgCl2).	Whenever	different	mutants	were	compared,	membrane	inputs	
were	 adjusted	with	 an	 immunoblot	 beforehand.	 Reactions	were	 incubated	 between	 0	min	 and	
180	min	at	30°C,	before	they	were	stopped	by	boiling	for	5	min	at	98°C.	Samples	were	cleared	by	
centrifugation	 (16’100	g,	1	min,	25°C)	and	 supernatants	were	 taken	up	 in	900	µl	 1	mM	sodium	
acetate.	Nucleotides	UDP	and	UDP-GlcNAc	were	separated	on	an	anion	exchange	column	 (1	ml	
Resource	Q,	GE	Healthcare)	mounted	on	an	ÄKTA	Purifier	FPLC	unit	(GE	Healthcare)	with	a	linear	
gradient	of	sodium	acetate	from	1	mM	to	1	M	and	monitored	with	Unicorn	software.	Initial	linear	
PgaCD	GT	reaction	velocities	were	determined	by	plotting	integrated	peak	areas	against	reaction	
incubation	times	using	GraphPad	Prism.	
	
C-di-GMP	capture	compound	(cdG-CC)	binding	assay	
CdG-CC	 (Caprotec	 Bioanalytics,	 Germany)	 experiments	 were	 carried	 out	 in	 200	µl	 12-tube	 PCR	
strips	 (Thermo	Scientific)	 as	previously	described	 (Nesper	et	al,	 2012)	with	 some	modifications.	
100	 µl	 samples	 generally	 contained	 membranes	 from	 strain	 AB1638	 harboring	 the	 desired	
plasmid	 (approximately	 3-4	mg/ml	 total	 protein)	 and	20	mM	UDP-GlcNAc	 in	Binding	Buffer	 (20	
mM	HEPES	pH	7.5,	50	mM	potassium	acetate,	10	mM	magnesium	acetate,	10%	glycerol,	5	mM	
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MgCl2,	1.5	mM	CaCl2).	Whenever	different	mutants	were	compared,	experiments	were	performed	
in	 the	 context	 of	 the	 PgaCD	 fusion	 protein	 and	 membrane	 inputs	 were	 adjusted	 with	 an	
immunoblot	 beforehand.	 A	 12.5-	 or	 125-fold	 molar	 excess	 of	 c-di-GMP	 or	 GTP	 was	 added	 to	
competition	 experiments	 and	 strips	 were	 preincubated	 for	 30	 min	 at	 30°C	 with	 end-over-end	
agitation.	After	the	addition	of	0.8	µM	or	8	µM	cdG-CC,	strips	were	wrapped	in	aluminum	foil	and	
incubated	for	2	h	at	30°C	with	end-over-end	agitation.	Samples	were	UV-irradiated	at	310	nm	for	
4	min	at	4°C	using	a	caproBox	(Caprotec	Bioanalytics,	Germany),	before	they	were	taken	up	in	a	
final	 volume	of	 200	µl	 Capture	 Solubilization	Buffer	 (50	mM	Tris	HCl	 pH	 7.5,	 1	mM	EDTA,	 1	M	
NaCl,	 0.5%	 DDM)	 and	 solubilized	 for	 4	 h	 at	 4°C	 with	 end-over-end	 agitation.	 After	
ultracentrifugation	 (100’000	g,	1	h,	4°C),	an	aliquot	of	 the	supernatants	was	saved	and	 the	 rest	
incubated	with	35	µl	magnetic	streptavidin	beads	(Dynabeads	MyOne	Streptavidin	C1,	Invitrogen)	
in	 PCR	 strips	 (Thermo	 Scientific)	 for	 40	 min	 at	 4°C	 with	 end-over-end	 agitation.	 Beads	 were	
collected	with	a	magnet	(caproMag,	Caprotec	Bioanalytics,	Germany)	and	washed	9x	with	200	µl	
Capture	Wash	Buffer	(50	mM	Tris	HCl	pH	7.5,	1	mM	EDTA,	1	M	NaCl,	0.1%	DDM),	before	captured	
proteins	were	 analyzed	 by	 immunoblots.	 If	 different	mutants	were	 compared,	 band	 intensities	
were	 quantified	 using	 the	 ImageJ	 software	 and	 band	 intensities	 were	 normalized	 to	 the	 total	
solubilized	protein	amount	of	each	sample.	
	
UV-crosslinking	with	[32/33P]c-di-GMP	
UV	light-induced	crosslinking	experiments	were	performed	as	previously	described	(Christen	et	al,	
2005,	 2006)	 in	 conical	 96-well	 plates	 (Greiner	 Bio-One).	 25	 µl	 samples	 generally	 contained	
membranes	from	strain	AB1638	harboring	p2-3xF	or	p6a	(approximately	30	mg/ml	total	protein)	
and	20	mM	UDP-GlcNAc	 in	Binding	Buffer	 (20	mM	HEPES	pH	7.5,	50	mM	potassium	acetate,	10	
mM	magnesium	acetate,	10%	glycerol,	5	mM	MgCl2,	1.5	mM	CaCl2).	Whenever	different	mutants	
were	 compared,	 membrane	 inputs	 were	 adjusted	 with	 an	 immunoblot	 beforehand.	 For	
competition	 experiments,	 a	 100-fold	molar	 excess	 of	 c-di-GMP	 or	GTP	was	 added.	 Plates	were	
preincubated	sealed	with	a	foil	for	35	min	at	30°C	on	a	rocking	platform,	before	the	addition	of	1	
µM	or	2	µM	radiolabeled	 [32/33P]c-di-GMP.	After	a	 second	 incubation	 for	2	h	at	30°C,	 foils	were	
removed	and	96-well	plates	were	UV-irradiated	at	254	nm	for	20	min	using	a	Bio-Link	crosslinker	
(Vilber	 Lourmat,	 France).	 Thereafter,	 samples	 were	 taken	 up	 in	 a	 final	 volume	 of	 200	 µl	
Crosslinking	Solubilization	Buffer	(50	mM	Tris	HCl	pH	7.5,	200	mM	NaCl,	5%	glycerol,	1	mM	DTT,	
0.5%	DDM)	and	solubilized	overnight	at	4°C	with	end-over-end	agitation.	After	ultracentrifugation	
(100’000	 g,	 1	 h,	 4°C),	 supernatants	 were	 incubated	 with	 40	 µl	 anti-Flag	 M2	 magnetic	 beads	
(Sigma)	overnight	at	4°C	with	end-over-end	agitation.	Beads	were	washed	multiple	times	with	IP	
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Wash	 Buffer	 B	 (50	mM	 Tris	 HCl	 pH	 7.5,	 1	M	 NaCl,	 5%	 glycerol,	 0.1%	 DDM)	 and	 the	 help	 of	 a	
magnet,	 before	 immunoprecipitated	 proteins	 were	 analyzed	 by	 Coomassie	 staining	 and	
autoradiography.	 If	 needed,	 band	 intensities	 were	 quantified	 using	 the	 ImageJ	 software	 and	
autoradiography	band	intensities	were	normalized	to	protein	amounts	on	Coomassie-stained	gels.	
	
Supplementary	data	
Supplementary	data	are	available	at	The	EMBO	Journal	Online	(http://www.embojournal.org).	
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Figure	legends	
Figure	 1	 C-di-GMP	 controls	 PgaD	 stability	 in	 a	 PgaC-dependent	 manner.	 (A)	 Schematic	
representation	 of	 the	 E.	 coli	 Pga	 machinery.	 See	 text	 for	 details.	 IM	 =	 inner	 membrane,	 PP	 =	
periplasm,	OM	=	outer	membrane.	(B)	Immunoblot	analysis	of	3xFlag-tagged	Pga	proteins	in	the	
E.	coli	control	strain	and	∆ydeH	mutant.	The	native	pga	promoter	(left	panel)	was	replaced	with	
the	Para	promoter	(right	panel).	Expression	of	the	araB-pgaA	translational	fusion	was	induced	with	
0.0002%	L-arabinose.	(C)	PgaD	levels	depend	on	PgaC	and	c-di-GMP.	Immunoblots	of	PgaD-3xFlag	
are	 shown	 for	 the	 indicated	 mutant	 strains.	 Expression	 of	 pgaC	 was	 induced	 with	 0.0002%	 L-
arabinose	 (left	 panel)	 and	 with	 0%,	 0.0002%	 and	 0.2%	 L-arabinose	 (right	 panel).	 (D)	 Graph	
showing	relative	PgaD	levels	upon	blocking	protein	biosynthesis	in	exponentially	growing	cells	as	
an	 average	 of	 two	 independent	 experiments	 with	 standard	 deviations.	 Expression	 of	 the	
heterologous	 DGC	 dgcA	 and	 its	 active	 site	 mutant	 dgcAmut	 (D164N)	 was	 not	 induced	 (leaky	
expression).	 (E)	 Biofilm	 formation	 of	 strains	 carrying	 multiple	 deletions	 in	 genes	 predicted	 to	
encode	DGCs.	The	∆7	strain	carries	a	total	of	seven	deletions	(∆ydeH,	∆ycdT,	∆yegE,	∆yfiN,	∆yhjK,	
∆ydaM,	 ∆yneF).	 Error	 bars	 are	 standard	 deviations.	 A	 representative	 dataset	 of	 the	 relative	
cellular	c-di-GMP	concentrations	of	the	strains	is	indicated.	n/a	=	not	available,	bld	=	below	limit	
of	detection.	Inset:	Immunoblot	of	PgaD-3xFlag	in	the	control	strain	and	the	∆7	mutant.	
	
Figure	 2	 C-di-GMP	 enhances	 PgaC-PgaD	 interaction.	 (A)	 PgaC-6xHis	 and	 PgaD-3xFlag	 co-
immunoprecipitate	 from	 detergent-solubilized	 membranes.	 Anti-Flag	 and	 protein	 A	 (mock)	 IPs	
were	 analyzed	 by	 immunoblots	 using	 antibodies	 against	 the	 specific	 tags.	 The	 protein	 fraction	
that	failed	to	bind	to	the	beads	is	indicated	(sn	=	supernatant).	2	M	urea	was	present	during	the	IP	
procedure	 as	 indicated.	 (B)	 Co-immunoprecipitation	 of	 PgaC	 and	 PgaD-3xFlag	 from	 detergent-
solubilized	membranes	of	 control	 strain	and	∆7	mutant	 cells	overexpressing	pgaC	 and	pgaD.	 IP	
samples	were	analyzed	by	Coomassie	staining.	HC	and	LC	mark	heavy	and	light	chains	of	IgG.	(C)	
Bacterial	two-hybrid	(BacTH)	analysis	of	PgaC-PgaD	interaction.	Presence	of	T18	and	T25	fusions	is	
indicated.	 Zip	 indicates	 the	 leucine	 zipper	 positive	 control.	 (D)	 BacTH	 analysis	 of	 c-di-GMP-
stimulated	PgaC-PgaD	interaction.	Left	panel:	Interaction	in	the	presence	of	a	plasmid-borne	copy	
of	dgcA	 or	 its	 active	 site	mutant	dgcAmut	 (D164N).	 Alleles	were	 induced	with	 0.2%	 L-arabinose.	
Right	panel:	Interaction	in	strains	lacking	the	DGC	YdeH	or	multiple	DGCs	(∆7).	See	Supplementary	
Figure	 2	 for	 the	 quantification	 of	 interaction	 strengths.	 (E)	 A	 PgaCD	 fusion	 protein	 is	 fully	
functional.	 Biofilm	 formation	 and	 protein	 levels	 of	 3xFlag-tagged	 PgaD	or	 PgaCD	 fusion	 protein	
(PgaCDf)	are	 indicated	 for	 the	control	 strain	 (black	bars)	and	a	∆ydeH	mutant	 (grey	bars).	 Error	
bars	are	standard	deviations.	
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Figure	 3	 C-di-GMP	 allosterically	 stimulates	 PgaCD	 glycosyltransferase	 activity	 in	 vitro.	 (A)	 GT	
activity	 depends	on	 an	 intact	 PgaCD	 complex.	 Enzyme	activities	were	determined	using	 control	
strain	membranes	containing	PgaC,	PgaD	or	both	proteins	in	the	presence	(2	mM)	or	absence	of	
the	 substrate	 UDP-GlcNAc.	 A	 representative	 dataset	 is	 shown.	 (B)	 Microscopic	 analysis	 of	 the	
viscous	poly-GlcNAc	reaction	product.	Membranes	were	incubated	with	30	mM	UDP-GlcNAc	for	5	
h	at	30°C.	Scale	bars	are	 indicated:	15	µm.	 (C)	Determination	of	 the	PgaCD	Km	 for	UDP-GlcNAc.	
Membranes	 of	 a	 ∆7	 mutant	 containing	 PgaC	 and	 PgaD	 were	 incubated	 with	 increasing	
concentrations	of	UDP-GlcNAc	 in	the	presence	of	1	µM	c-di-GMP.	Data	represent	an	average	of	
two	 independent	 experiments	 with	 standard	 deviations.	 (D)	 Stimulatory	 effect	 of	 c-di-GMP	 on	
PgaCD	GT	activity	 (Kact).	Membranes	of	 a	∆7	mutant	 containing	PgaC	and	PgaD	were	 incubated	
with	 increasing	 concentrations	 of	 c-di-GMP	 in	 the	 presence	 of	 50	 µM	 UDP-GlcNAc.	 A	
representative	 dataset	 is	 shown.	 (E)	 Lineweaver-Burk	 plot	 analysis	 of	 PgaCD	 GT	 activity.	
Membranes	 of	 a	 ∆7	 mutant	 containing	 PgaC	 and	 PgaD	 were	 incubated	 with	 increasing	
concentrations	of	UDP-GlcNAc	in	the	presence	of	a	non-saturating	(0.03	µM)	and	a	saturating	(1	
µM)	 c-di-GMP	 concentration.	 Negative	 reciprocal	 Km	 is	 indicated.	 A	 representative	 dataset	 is	
shown.	GraphPad	Prism	was	used	for	curve	fitting	and	linear	regression.	a.u.	=	arbitrary	unit.	
	
Figure	4	Specific	binding	of	c-di-GMP	requires	PgaC	and	PgaD.	(A)	Immunoblot	of	PgaD	captured	
from	 membranes	 containing	 PgaC	 and	 PgaD-3xFlag.	 Presence	 of	 cdG-CC	 and	 competing	
nucleotides	 is	 indicated.	 (B)	 Immunoblots	 of	 PgaC,	 PgaD	 and	 PgaCD	 fusion	 protein	 (PgaCDf)	
captured	 from	 membranes	 containing	 PgaC	 and	 PgaD-3xFlag	 (1st	 panel),	 PgaCDf-3xFlag	 (2nd	
panel),	PgaC-3xFlag	(3rd	panel),	PgaD-3xFlag	(4th	panel)	or	PgaC-3xFlag	and	PgaD-3xFlag	(5th	panel).	
Presence	of	 cdG-CC	and	 competing	nucleotides	 is	 indicated.	 SDS-resistant	heterodimeric	 PgaCD	
complexes	 are	 indicated	 (PgaCD).	 (C)	 Specific	 labeling	 of	 PgaC	 and	 PgaD	 with	 [33P]c-di-GMP.	
Membranes	 containing	 PgaC-3xFlag	 and	 PgaD-3xFlag	 were	 UV-crosslinked	 in	 the	 presence	 of	
[33P]c-di-GMP	 and	 competing	 nucleotides	 as	 indicated.	 Coomassie	 staining	 (left	 panel)	 and	
autoradiography	 (right	 panel)	 are	 shown.	 HC	 and	 LC	mark	 heavy	 and	 light	 chains	 of	 IgG.	 SDS-
resistant	heterodimeric	PgaCD	complexes	are	indicated	(PgaCD).	(D)	Absence	of	PgaD	abolishes	c-
di-GMP	binding.	Membranes	containing	PgaC-3xFlag	and	PgaD-3xFlag	(left	panels)	or	PgaC-3xFlag	
(right	panel)	were	UV-crosslinked	in	the	presence	of	[32P]c-di-GMP	and	competing	nucleotides	as	
indicated.	Only	autoradiographies	are	shown.	
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Figure	5	Mutations	in	PgaD	render	the	PgaCD	complex	constitutively	active	and	independent	of	c-
di-GMP.	(A)	Predicted	topology	of	PgaD.	Positions	of	c-di-GMP-independent	(orange)	and	loss-of-
function	mutations	(red)	within	the	most	conserved	region	of	PgaD	(grey)	are	indicated.	Sites	of	C-
terminal	 PgaD	 truncations	 are	 marked	 by	 triangles.	 IM	 =	 inner	 membrane,	 PP	 =	 periplasm.	
Transmembrane	helices	were	predicted	using	the	TMHMM	server	(Sonnhammer	et	al,	1998).	(B)	
Biofilm	 formation	 of	 strains	 expressing	 C-terminally	 truncated	 pgaD	 alleles	 as	 a	 function	 of	
cellular	c-di-GMP	concentrations.	The	last	residue	of	each	mutant	is	indicated	(see	Figure	5A).	∆7	
strains	harboring	 individual	pgaD	 alleles	 contained	plasmids	with	 an	 IPTG-inducible	 copy	of	 the	
heterologous	DGC	wspR	(pwspR)	or	control	plasmids	(vector).	Expression	of	plasmid-borne	pgaD	
alleles	 was	 induced	 with	 0.2%	 (left	 graph)	 and	 0.02%	 L-arabinose	 (right	 graph).	 Error	 bars	 are	
standard	 deviations.	 (C)	 Contribution	 of	 pgaD	 mutants	 to	 biofilm	 formation	 is	 shown	 in	 the	
control	 strain	 (black	 bars)	 and	 the	 ∆7	 mutant	 (grey	 bars).	 Isolated	 constitutive	 alleles	 are	
underlined.	Error	bars	are	standard	deviations.	(D)	Immunoblot	analysis	of	steady	state	levels	of	
wild-type	and	mutant	forms	of	PgaD-3xFlag	in	the	control	strain	and	the	∆7	mutant.	(E)	C-di-GMP-
dependent	 PgaCD	GT	 activity.	Membranes	 of	 a	 ∆7	mutant	 containing	 either	 PgaD	wild-type	 or	
mutant	forms	were	incubated	with	(black	bars)	or	without	c-di-GMP	(grey	bars)	in	the	presence	of	
300	 µM	 UDP-GlcNAc.	 PgaD	 mutant	 variants	 were	 expressed	 as	 PgaCD	 fusion	 proteins.	 A	
representative	dataset	 is	shown	with	standard	errors.	a.u.	=	arbitrary	unit.	 (F)	The	PgaD	mutant	
N75D,K76E	 is	 strongly	 impaired	 in	 c-di-GMP	 binding.	 Relative	 amounts	 of	 PgaD	 wild-type	 or	
mutant	forms	captured	in	the	presence	(black	bars)	or	absence	of	excess	c-di-GMP	(grey	bars)	are	
shown	 as	 an	 average	 of	 two	 independent	 experiments	with	 standard	 deviations.	 PgaD	 variants	
were	expressed	as	PgaCD	fusion	proteins.	
	
Figure	 6	 A	 constitutive	 PgaD	 mutant	 rescues	 a	 PgaC	 mutant	 unable	 to	 bind	 c-di-GMP.	 (A)	
Constitutive	pgaC	mutants	show	partial	c-di-GMP	independence.	Contribution	of	pgaC	mutants	to	
biofilm	 formation	 is	 shown	 in	 the	 control	 strain	 (black	 bars)	 and	 the	 ∆7	 mutant	 (grey	 bars).	
Isolated	 constitutive	 alleles	 are	 underlined.	 Error	 bars	 are	 standard	 deviations.	 (B)	 Immunoblot	
analysis	of	PgaD-3xFlag	in	the	control	strain	and	the	∆7	mutant	expressing	different	pgaC	alleles.	
(C)	Mutational	analysis	of	conserved	arginine	residues	of	PgaC	(see	text	and	Supplementary	Figure	
6D).	 Biofilm	 formation	 was	 determined	 for	 strains	 expressing	 the	 respective	 PgaC	 variants	 as	
PgaCD	 fusion	 proteins.	 R198D	 was	 included	 as	 a	 control	 as	 this	 arginine	 is	 also	 conserved	 in	
organisms	that	 lack	c-di-GMP.	Error	bars	are	standard	deviations.	(D)	The	PgaC	R222A	mutant	 is	
strongly	impaired	in	c-di-GMP	binding.	A	representative	dataset	of	the	relative	amounts	of	PgaC	
wild-type	or	mutant	 forms	captured	 in	the	presence	(black	bars)	or	absence	of	excess	c-di-GMP	
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(grey	bars)	is	shown.	PgaC	variants	were	expressed	as	PgaCD	fusion	proteins.	(E)	The	constitutive	
PgaD	N75D,K76E	mutant	 rescues	 the	PgaC	R222A	mutant	deficient	 in	c-di-GMP	binding.	Biofilm	
formation	was	determined	for	strains	expressing	different	pgaC	and/or	pgaD	alleles	in	the	control	
strain	(black	bars)	and	the	∆7	mutant	(grey	bars).	Error	bars	are	standard	deviations.	
	
Figure	 7	 C-di-GMP	directly	 binds	 to	 both	PgaC	 and	PgaD.	Membranes	 containing	wild-type	 and	
mutant	forms	of	PgaC-3xFlag	and/or	PgaD-3xFlag	were	UV-crosslinked	in	the	presence	of	[32P]c-di-
GMP	and	with	(black	bars)	or	without	excess	c-di-GMP	(grey	bars).	
Quantification	of	PgaC	(left	graph)	and	PgaD	(right	graph)	band	intensities	from	(A)	as	an	average	
of	two	independent	experiments	with	standard	deviations.	Relative	PgaC	(upper	graph)	and	PgaD	
(lower	 graph)	 autoradiography	 band	 intensities	 are	 shown	 as	 an	 average	 of	 two	 independent	
experiments	with	standard	deviations.		
	
Figure	 8	 Model	 for	 the	 allosteric	 activation	 of	 the	 PgaCD	 glycosyltransferase	 complex	 by	 c-di-
GMP.	 (A)	 Topology	 models	 for	 PgaC	 and	 PgaD	 in	 the	 inner	 membrane.	 Orientations	 of	 PgaC	
transmembrane	 domains	 (TMDs)	 are	 based	 on	 this	 study,	 on	 TMHMM	 server	 predictions	
(Sonnhammer	 et	 al,	 1998),	 on	 the	 proposed	 topology	 of	 the	 PgaC	 homologue	 from	 Y.	 pestis	
(Bobrov	et	al,	 2008)	and	on	a	model	proposed	 for	 the	hyaluronan	 synthase	 from	Streptococcus	
pyogenes	 (Heldermon	 et	 al,	 2001;	 Weigel	 and	 DeAngelis,	 2007).	 TMDs	 1,	 2,	 4	 and	 5	 are	 true	
transmembrane	 domains,	 while	 3	 and	 6	 are	 membrane-associated	 domains	 (MADs).	 Catalytic	
domains	 A	 and	 B	 with	 the	 active	 site	 of	 processive	 GT-2	 b-glycosyltransferases	 are	 indicated	
(Saxena	 and	 Brown,	 1997;	 Saxena	 et	 al,	 2001).	 Regions	 proposed	 to	 be	 involved	 in	 c-di-GMP	
binding	are	highlighted	in	red.	The	position	of	the	constitutive	PgaC	mutation	V227L	is	indicated.	
CP	 =	 cytoplasm,	 IM	 =	 inner	 membrane,	 PP	 =	 periplasm.	 (B)	 C-di-GMP	 binding	 to	 the	 PgaCD	
complex	stabilizes	a	heterodimeric	complex	to	induce	a	secretion-competent	conformation.	Left:	
Top-view	of	the	inactive	transient	state	with	loosely	associated,	highly	unstable	PgaD.	Right:	C-di-
GMP	 binding	 induces	 a	 poly-GlcNAc	 secretion-competent	 state.	 (C)	 Model	 for	 the	 irreversible	
inactivation	 of	 PgaCD	 upon	 drop	 of	 cellular	 c-di-GMP	 levels.	 Signaling	 through	 the	 Csr	 cascade	
induces	 the	 synthesis	 of	 Pga	 components	 and	 the	 DGCs	 YdeH	 and	 YcdT.	 At	 low	 c-di-GMP	
concentrations	(e.g.	inactive	DGCs	or	highly	active	PDEs)	PgaD	is	rapidly	removed	by	proteolysis,	
uncoupling	the	Pga	machinery	temporarily	from	c-di-GMP	signaling.	Only	continuous	or	renewed	
input	 through	 the	 Csr	 signaling	 cascade	will	 allow	 cells	 to	 reactivate	 poly-GlcNAc	 synthesis	 and	
secretion,	 thus	 providing	 the	 Csr	 cascade	 with	 signaling	 dominance	 over	 the	 enzymes	 directly	
regulating	the	cellular	c-di-GMP	level.	





















